These observations provide preliminary evidence that microRNAs such as miR-20b may be a therapeutic approach to modulate PPARG-related transcriptomic changes associated with neurodegeneration and cognitive decline in T2DM. Here, PPARG is linked to type 2 diabetes mellitus.